Edward T Mathers's Net Worth
Estimate Recalculated Nov 11, 2024 01:40PM EST
Who is Edward T Mathers
Edward T Mathers does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Savara Inc, Trevi Therapeutics, Inc., Mirna Therapeutics, Inc., Akouos, Inc., Ra Pharmaceuticals, Inc., Senti Biosciences, Inc., ObsEva SA, Liquidia Technologies Inc, MEDIMMUNE INC /DE, and Korro Bio, Inc..
SEC CIK
Edward T Mathers's CIK is 0001328625
Past Insider Trading and Trends
2021 was Edward T Mathers's most active year for acquiring shares with 8 total transactions. Edward T Mathers's most active month to acquire stocks was the month of May. 2007 was Edward T Mathers's most active year for disposing of shares, totalling 7 transactions. Edward T Mathers's most active month to dispose stocks was the month of May. 2006 saw Edward T Mathers paying a total of $954,200.00 for 260,000 shares, this is the most they've acquired in one year. In 2006 Edward T Mathers cashed out on 80,000 shares for a total of $1,303,420.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
